2,486 results on '"Page, Clive"'
Search Results
2. The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
3. Macrolides and Diseases Associated with Loss of Epithelial Barrier Integrity
4. Macrolides and Diseases Associated with Loss of Epithelial Barrier Integrity
5. Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airways
6. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
7. Systematic literature review of treatments used for refractory or unexplained chronic cough in adults
8. Profiling alveolar macrophage responses to inhaled compounds using in vitro high content image analysis
9. Prospects for macrolide therapy of asthma and COPD
10. Phosphodiesterase inhibitors and lung diseases
11. Investigation into P2Y Receptor function in platelets from patients with sepsis
12. LPS-induced Lung Platelet Recruitment Occurs Independently from Neutrophils, PSGL-1, and P-Selectin
13. Antitussive Drugs
14. Perspectives of Pharmacology over the Past 100 Years
15. The discovery and development of gefapixant as a novel antitussive therapy
16. Prospects for COPD treatment
17. Doxofylline: Advancing and Empowering Equitable Asthma and COPD Management Beyond Tradition.
18. Bifunctional Drugs for the Treatment of Respiratory Diseases
19. Pathogenesis of COPD and Asthma
20. Platelets and Airway Diseases
21. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent
22. Imaging drugs, metabolites and biomarkers in rodent lung: a DESI MS strategy for the evaluation of drug-induced lipidosis
23. The rabbit as a biomedical model.
24. Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients
25. Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways
26. Antitussive therapy: A role for levodropropizine
27. 4 - Pharmacology
28. Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders.
29. What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trials
30. Tozorakimab in patients hospitalised with COVID-19: a phase 2, randomised adaptive platform study (ACCORD-2)
31. In vivo inflammation resolving effect of EP395
32. Heparin and Related Molecules: Antiproliferative and Anti-Inflammatory Effects in the Airways
33. The cardiovascular effects of xanthines and selective PDE inhibitors: a risk–benefit analysis
34. Antitussive Drugs
35. Red Blood Cells Elicit Platelet-Dependent Neutrophil Recruitment into Lung Airspaces
36. Red Blood Cells Elicit Platelet-Dependent Neutrophil Recruitment Into Lung Airspaces
37. Impact of doxofylline in COPD: A pairwise meta-analysis
38. β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseases
39. Realising the potential of various inhaled airway challenge agents through improved delivery to the lungs
40. Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue
41. Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: A pilot study
42. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis
43. Steroid sparing effects of doxofylline
44. A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy
45. A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2
46. Revisiting Asthma Pharmacotherapy: Where Do We Stand and Where Do We Want to Go?
47. Novel Anti-Inflammatory Approaches to COPD
48. Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study
49. Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022
50. Azithromycin ameliorates sulfur dioxide-induced airway epithelial damage and inflammatory responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.